Most stocks fall 55% from their highs because the business is deteriorating. Oracle is the exception.
The business isn’t deteriorating. In fact, by almost every demand-side metric, Oracle just put up the strongest year in its history. The market is selling it anyway. That’s the tension worth understanding here — because the options flow is starting to shift.
The Numbers Behind the Disconnect
Oracle closed fiscal 2026 with $638 billion in remaining performance obligations — contracted work signed but not yet delivered. That figure jumped 363% from a year earlier.
In the most recent quarter, Oracle said it signed $67 billion in AI infrastructure contracts, with GPU utilization at 97.5% across its global network.
Yet the stock traded near $132 as of July 15, off a 52-week high of $345.72. That’s a stock priced like a company with a deteriorating order book, not one sitting on years of contracted revenue at the current run rate.
So what’s the market actually pricing?
Timing and cash. Oracle reported free cash flow of negative $23.7 billion in fiscal 2026 as it accelerated investment in infrastructure, while operating cash flow was about $32.0 billion.
On the financing side, Oracle said it raised $43 billion in debt and $5 billion in equity during fiscal 2026. That raises real questions about dilution risk and execution risk on one of the largest data center build-outs in corporate history.
And only about 12% of that $638 billion backlog converts to revenue in the next 12 months. Another 34% comes in months 13 to 36. The rest is spread over years. The market is being asked to fund a massive capex cycle today in exchange for revenue that arrives gradually over the better part of a decade.
That’s a hard ask. Especially when gross margins are expected to step down in the near term as the infrastructure ramp-up absorbs the cost base before scale kicks in.
What the Options Market Is Saying Right Now
Here’s where it gets interesting. As of July 14–15, Oracle’s options chain is showing a call-to-put ratio of approximately 2.2:1, with notable positioning concentrated in July 31 weekly calls. Put volume came in at roughly 97,679 contracts versus call volume of 257,039. That’s a call-heavy skew that’s difficult to ignore.
Oracle’s 30-day implied volatility sits at 63, against a 52-week range of 31 to 85. That places IV at roughly the midpoint of its annual range — not cheap, but not extended. For traders who believe the stock has found a near-term floor around the $130–$135 zone, the IV environment doesn’t penalize defined-risk positioning the way it would at peak volatility.
Piper Sandler has maintained an Overweight/Buy-equivalent stance with a $225 price target. Analyst consensus targets vary by source; one widely cited compilation put the average around $252 in early July.
Slight tangent, but it matters: Oracle has been reported as a leading participant in discussions around a Japan “secret cloud” national security initiative. Details and final contract awards are not yet clear from primary government documentation, so treat this as an emerging headline rather than booked backlog.
The Trade Framework
For traders who believe the $130 level holds and that the AI build-out thesis is intact over 12 to 18 months: a defined-risk bull call spread in the August or September expiration, targeting a recovery toward the $160–$180 range, keeps downside capped while participating in a potential mean-reversion move. The call-heavy open interest in late July expirations suggests the market is starting to lean that way.
For those who think the capex burden gets worse before it gets better: a bear put spread targeting a flush toward the $120 area would be the defined-risk expression of that view. The free cash flow deficit and the dilution math are real risks, not hypothetical ones.
The neutral case — calendar spreads or selling elevated short-dated premium against longer-dated long calls — makes sense if you believe Oracle is rangebound while the market waits for backlog conversion evidence.
The core question isn’t whether Oracle has demand. It clearly does. The question is whether a multi-year revenue recognition schedule and heavy infrastructure investment are manageable at the scale Oracle is attempting. Management says yes. The stock is voting no. The options market, right now, is starting to side with management.
That divergence is worth watching closely.
